Cervical Epidural Injections: Different Approaches, Different Risks
By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine
Published November 11, 2025 | Category: Pain Medicine
Cervical epidural steroid injections can be performed between the vertebrae (interlaminar, IL) or through the opening where the nerve exits the spine (transforaminal, TF). Debate continues over which approach is safer. A study in Spine used a large national database to compare neurological complications between the two.
This summary is based on the published abstract. Read the abstract on PubMed
What the authors did
The authors identified adults who underwent cervicothoracic IL or TF injections in a large national, multi-insurance database. They calculated the rate of neurological complications and compared the odds of specific events within 48 hours, adjusting for age, sex and other conditions.
What they found
- The study included 1,073,215 IL patients and 220,597 TF patients.
- Overall neurological complication rates were similar: 4.15 per 1,000 for IL and 4.56 per 1,000 for TF.
- TF injections had higher odds of nerve root injury (about 69% higher).
- TF injections had lower odds of epidural hematoma (about 40% lower).
- Other neurological adverse events did not differ significantly.
The authors conclude that adverse events are rare but not absent, and that neither approach is universally safer.
Why this matters
Each approach carries its own risks. Understanding these differences helps physicians select the right approach for each patient, for example considering bleeding risk or nerve anatomy, and explain risks accurately.
Limitations
Database studies rely on billing codes and cannot confirm that the injection caused a complication. Details such as steroid type and imaging technique were not available.
Safety takeaways: how to apply it
For pain physicians and procedure teams
- Choose the approach based on patient anatomy, bleeding risk and other factors, and document the reasoning.
- Follow technique-specific safety measures, such as contrast confirmation and non-particulate steroid for TF injections, and careful bleeding-risk assessment for IL injections.
- Discuss the specific risks of the chosen approach during informed consent.
For hospitals, clinics and safety leaders
- Track neurological complications after cervical injections by approach.
For patients and families
- Ask why a particular approach was chosen, and report new weakness, numbness or severe pain after the injection.
Reference
- Seddio AE, McNamara KF, Gouzoulis MJ, Jabbouri SS, Vasudevan RS, Day W, et al. Comparable Overall Risk of Neurological Adverse Events Following Cervicothoracic Interlaminar and Transforaminal Epidural Injections: An Analysis of 1.29 Million Patients. Spine (Phila Pa 1976). 2025 Sep 15;50(18):1273-1277. doi:10.1097/BRS.0000000000005181. PMID: 39394649. PubMed: https://pubmed.ncbi.nlm.nih.gov/39394649/
This article is educational information, not legal or medical advice.